Musk will attend a virtual all-hands meeting as his $44 billion acquisition of the company moves ahead, despite his hand-wringing about bots.
The White House is facing new questions about whether it acted quickly enough after the leading baby formula plant shut down in February.
The recent shutdown of one of the largest production plants in the United States has sent families scrambling to find essential food for their children.
Agency inspectors found a leaking roof, standing water and cracked production equipment before a facility shutdown that led to major shortages.
The government has ordered more safeguards at an Abbott Nutrition plant. But the lack of reporting requirements and limited testing make it hard to monitor the deadly bacterium that led to a recall.
With just a handful of companies making U.S. infant formula, a shutdown of Abbott’s plant had outsized impact on the supply.
A day after invoking the Defense Production Act to help alleviate a nationwide shortage, administration officials had few answers for how the law would lead to more supply.
The president invoked the Defense Production Act to boost supply and directed federal agencies to use Defense Department planes to speed shipments of formula from overseas.
The formula shortage is temporary. Changes to WIC should be permanent.
Why is the wealthiest country in the world struggling to provide basic nutrition to so many children?
The company said if the agency approved reopening the plant, production could resume and store shelves would be restocked within several weeks.
The shortage highlights four larger problems with the U.S. economy.
Some parents are driving hours at a time in search of supplies. Others are watering down formula or rationing it, hoping for an end to the shortage.
After Abbott Nutrition issued voluntary recalls of its popular baby formulas, retailers have limited purchases, leaving desperate parents searching for solutions.
The new findings are from an ongoing U.S. study that began in October and was designed to assess the performance of rapid antigen tests in asymptomatic people.
Millions of Americans are now receiving tests through the new mail program, which health experts said came too late to meet demand during the brunt of Omicron wave.
A new study adds to evidence that common rapid tests may fail to detect some Omicron cases in the first days of infection.
One of the leading producers of rapid tests purged supplies and laid off workers as sales dwindled. Weeks later, the U.S. is facing a surge in infections with diminished capacity.
But does it work?
Testing companies have revealed little about how their products perform in minors. That could be a problem.
In a small study in San Francisco, Abbott’s BinaxNOW identified infectious people nearly as accurately as a P.C.R. test.
Two tests made by Quidel and BD repeatedly delivered false-positive results, prompting the state to stop using them.
Federal officials relied too heavily on the tests, then took the results for granted, experts say.
Six months into the pandemic and with no coherent national testing strategy, the Trump administration is encouraging private development of an array of faster and cheaper techniques.
The usual diagnostic tests may simply be too sensitive and too slow to contain the spread of the virus.
Declining antibody levels do not mean less immunity, experts say. Besides, two widely used tests may detect the wrong antibodies.
A study found that the Abbott ID Now machine was less accurate when it processed short, dry swabs.
In a Fox News Channel interview, Mr. Trump also angrily revived grievances about special counsel Robert S. Mueller III and promised a swift economic rebound.
President Trump said he and Vice President Mike Pence, as well as the White House staff, would now be tested on a daily basis.
In both red and blue states, governors, health departments and hospitals are finding innovative ways to cope, but still lack what experts say they need to track and contain outbreaks.